The Serialization Trend

Over the past few years, medicine counterfeiting has become very common around the world.
For several years, the European Union (EU) has been concerned about the growing threat of counterfeit or ‘falsified’ medicines to public health and safety.
In 2011, the European Commission (EC) started working to amend Directive 2001/83/EC that addresses these concerns under the Falsified Medicines Directive (FMD). The final phase of the FMD is due to be rolled out from 9 February 2019.

The FMD is designed to protect patients by minimizing the chances of counterfeit medicines entering the established medicines supply chain across Europe. It will enable manufacturers, wholesalers, distributors and everyone who supplies to patients to verify the authenticity of a medicinal product, identify individual packs and check whether the outer packaging of medicines has been tampered with.

Considering the level of know-how needed to address this issue, in-house solution is essentially impossible.
Pharmatronik is committed to help customers to reach their goals with innovative and tailor-made solutions, both on the software and the hardware end. Not only do our solutions meet and exceed the current serialization legislation but they are also able to flexibly adapt to all upcoming regulations.